Litman Gregory Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-28
Closed -$1K 102
2018
Q1
$1K Buy
+28
New +$1.33K ﹤0.01% 163

Other funds holding AVNS

Litman Gregory Wealth Management's AVNS Position: Q2 2018 in Review

Litman Gregory Wealth Management sold out of Avanos Medical (AVNS) in Q2 2018, closing a stake of 28 shares — an estimated $1K sold.

Litman Gregory Wealth Management first reported a position in AVNS in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 321 funds tracked by Wall St. Rank hold AVNS as of Q2 2018.

  • Litman Gregory Wealth Management reported no remaining Avanos Medical position as of Q2 2018 after selling out during the quarter.
  • Litman Gregory Wealth Management sold 28 Avanos Medical shares in Q2 2018, an estimated $1K.
  • Litman Gregory Wealth Management first reported a position in Avanos Medical in Q1 2018 and held it in 1 quarter.
  • Litman Gregory Wealth Management's Avanos Medical position peaked at $1K in Q1 2018.
  • 321 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2018.

Based on Litman Gregory Wealth Management's 13F filing for Q2 2018, filed 9 Aug 2018.